CLINICAL_TRIALS
trial_result
· 2014-07-28
Clinical Trial Update: Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke [Phase 4]
Summary
Phase 4 study by Medtronic assessed continuous cardiac monitoring to detect atrial fibrillation after cryptogenic transient ischemic attack or cryptogenic ische…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Medtronic Cardiac Rhythm and Heart Failure | Conditions: Cryptogenic Symptomatic Transient Ischemic Attack, Cryptogenic Ischemic Stroke | Phase 4 | Status: COMPLETED | Results posted: 2014-07-28